BetterLife Pharma (BETRF) Stock Price, News & Analysis

Company Overview

BetterLife Pharma (OTCMKTS:BETRF) is a life sciences company specializing in the development, manufacture and distribution of health and wellness products. The company’s core business activities include nutraceutical research, formulation of dietary supplements and production of personal care solutions. BetterLife Pharma positions itself at the intersection of modern science and traditional wellness, focusing on natural ingredients and evidence-based formulations aimed at supporting immune health, cognitive function and overall vitality.

Through a diversified product portfolio, BetterLife Pharma offers vitamins, minerals and botanical extracts designed to meet the needs of a broad consumer base. The company has expanded into advanced topical formulations, including anti-aging serums and therapeutic skincare lines. It also markets a range of specialty products targeting inflammation relief, metabolic support and stress management, leveraging proprietary extraction techniques to enhance bioavailability and efficacy.

Founded in 2018 and headquartered in Vancouver, Canada, BetterLife Pharma has grown its global footprint by establishing strategic partnerships across North America, Europe and Asia Pacific. The company distributes its products through an omni-channel approach that includes direct-to-consumer e-commerce platforms, third-party online retailers and select retail pharmacy chains. This multi-channel model enables BetterLife Pharma to reach health-conscious consumers in over 20 countries, while maintaining flexible supply chain operations and quality control standards in its ISO-certified manufacturing facilities.

BetterLife Pharma’s leadership team is led by CEO Alexander Orenstein, who brings over 15 years of experience in the nutraceutical industry and a background in pharmaceutical research. The senior management team also includes Chief Scientific Officer Dr. Maya Patel, responsible for overseeing the company’s R&D initiatives, and CFO Claire Zhang, who manages financial strategy and investor relations. Under their guidance, BetterLife Pharma continues to invest in clinical studies and strategic collaborations aimed at expanding its pipeline of innovative wellness solutions.

Key Stats

• Today's Range: $0.07 to $0.07
• 50-Day Range: $0.06 to $0.09
• 52-Week Range: $0.05 to $0.14
• Volume: 10,200 shs
• Average Volume: 16,294 shs
• Market Capitalization: $10.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BETRF Stock Analysis - Frequently Asked Questions

How have BETRF shares performed this year?

BetterLife Pharma's stock was trading at $0.0720 on January 1st, 2025. Since then, BETRF stock has decreased by 0.4% and is now trading at $0.0717.

How do I buy shares of BetterLife Pharma?

Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/19/2025
• Next Earnings (Estimated): 9/23/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:BETRF
• CIK: 1464165
• Web: www.abetterlifepharma.com
• Phone: 604-221-0595
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.55 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -609.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.04
• Quick Ratio: 0.04

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -1.79

Miscellaneous

• Outstanding Shares: 151,840,000
• Free Float: 99,045,000
• Market Cap: $10.89 million
• Optionable: Not Optionable
• Beta: 1.45